
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.550 | 4.320 | 0.770 |
Shares | 96.440 | 96.440 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.488 | 17.685 |
Price to Book | 3.231 | 3.321 |
Price to Sales | 2.332 | 2.158 |
Price to Cash Flow | 14.092 | 13.960 |
Dividend Yield | 2.933 | 2.947 |
5 Years Earnings Growth | 18.544 | 13.939 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 31.750 | 30.903 |
Financial Services | 22.990 | 20.967 |
Consumer Defensive | 13.550 | 12.593 |
Industrials | 12.460 | 16.403 |
Basic Materials | 9.210 | 8.265 |
Consumer Cyclical | 7.430 | 5.341 |
Technology | 2.610 | 3.511 |
Number of long holdings: 34
Number of short holdings: 3
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 9.05 | 98.24 | -0.19% | |
Roche Holding Participation | CH0012032048 | 8.89 | 306.00 | -1.03% | |
Nestle | CH0038863350 | 7.70 | 89.76 | -0.82% | |
UBS Group | CH0244767585 | 5.58 | 29.06 | -1.62% | |
Holcim | CH0012214059 | 5.24 | 100.85 | +0.35% | |
ABB | CH0012221716 | 4.62 | 50.98 | +2.82% | |
Zurich Insurance Group | CH0011075394 | 4.60 | 609.80 | +0.46% | |
Richemont | CH0210483332 | 4.44 | 165.00 | +0.82% | |
Swiss Re | CH0126881561 | 3.79 | 149.10 | -0.03% | |
Sika | CH0418792922 | 3.64 | 230.40 | -0.22% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Kapital Plus P EUR | 7.47M | 0.91 | -2.17 | 2.49 | ||
DE000A2DU1Y2 | 17.36M | -0.15 | -3.20 | 1.46 | ||
Kapital Plus A EUR | 2.61B | 0.40 | -2.67 | 2.01 | ||
Kapital Plus I EUR | 96.78M | 2.43 | 0.24 | 2.33 | ||
Kapital Plus P2 EUR | 2.32M | 2.45 | 0.39 | 2.48 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review